BioTech Nation Podcast: Fighting Inflammation, and Alzheimer’s: Dr. David Bearss, President & CEO Halia Therapeutics
April 4, 2024
A recent episode of BioTechNation features Dr. David Bearss, CEO of Halia Therapeutic. Bearss discusses inflammation and unveils the potential of the inflammasome in treating diseases where inflammation plays a critical role, such as Alzheimers.
Recent News
- BioUtah Member Appreciation BBQ 2026 Recap
- Epitel Adds Proven Medtech Leader James Reinstein to Board As Company Enters Next Stage of Growth
- Lipocine Announces Initiation of BLOOM Phase 3 Study of LPCN 1154 for Postpartum Depression
- CLENE ANNOUNCES $4 MILLION REGISTERED DIRECT OFFERING
- Co-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with Ebola
- Myriad Genetics Appoints Vishal Sikri Executive Vice President – Commercial
